Company Filing History:
1 out of 89 
1 out of 109 
1 out of 6 Years Active: 1987-1989
Title: The Innovative Contributions of James E. Geever
Introduction
James E. Geever is a notable inventor based in Bourbonnais, IL (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 3 patents to his name, Geever has made strides in developing new peptides with potential therapeutic applications.
Latest Patents
Geever's latest patents include innovative formulations of hypocalcaemic peptides. One of his notable inventions is the analogs of [1,7-di-alanine, des-19-leucine]calcitonin, which presents a new class of peptides characterized by specific acyl groups and amino acid substitutions. Another significant patent involves des-19-leucine, 20-glutamine-calcitonin, which describes peptides that maintain biological activity similar to known calcitonins while omitting specific amino acids. These advancements highlight Geever's expertise in peptide chemistry and its applications in medicine.
Career Highlights
Throughout his career, Geever has worked with prominent pharmaceutical companies, including Armour Pharmaceutical Company and Rorer Pharmaceutical Corporation. His experience in these organizations has contributed to his understanding of drug development and innovation in the pharmaceutical industry.
Collaborations
Geever has collaborated with notable professionals in his field, including Ronald C. Orlowski and Jay K. Seyler. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
James E. Geever's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patented peptides demonstrate his commitment to advancing medical science and improving therapeutic options.